{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:59:22Z","timestamp":1781643562496,"version":"3.54.5"},"reference-count":107,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Natural Science Research Project of Anhui Educational Committee","award":["2022AH050508"],"award-info":[{"award-number":["2022AH050508"]}]},{"name":"the Research Project of Anhui Provincial Health Commission","award":["AHWJ2023A30144"],"award-info":[{"award-number":["AHWJ2023A30144"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Adenosine-related RNA modifications, including N6-methyladenosine (m\n                      <jats:sup>6<\/jats:sup>\n                      A), N1-methyladenosine (m\n                      <jats:sup>1<\/jats:sup>\n                      A), alternative polyadenylation (APA), and adenosine-to-inosine (A-to-I) editing, critically regulate transcriptional programs in cancer. However, their coordinated contribution to bladder cancer biology and response to immunotherapy remains poorly understood.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We systematically characterized four classes of RNA modification \u201cwriter\u201d genes in bladder cancer, assessing somatic mutations, copy-number variations, and mRNA expression patterns across seven independent cohorts, including TCGA-BLCA, E-MTAB-4321, and GEO datasets (GSE32894, GSE13507, GSE48276, GSE70691, and GSE69795). Unsupervised consensus clustering identified RNA modification-based molecular subtypes, which were used to construct an RNA modification-based prognostic and immunotherapy response score (RMP_Score). This score was validated across multiple external cohorts, including the IMvigor210 anti-PD-L1 dataset. Differentially expressed genes (DEGs) between subtypes were assessed and integrated through Kaplan-Meier survival analysis and Cox proportional hazards regression to construct the RMP_Score. Bulk and single-cell transcriptomic analyses, complemented by in vitro functional assays, were performed to investigate the role of carboxylesterase 1 (CES1), a key component of the RMP_Score. Tumor microenvironment (TME) composition was quantified using single-sample gene set enrichment analysis (ssGSEA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>RNA modification \u201cwriter\u201d genes exhibited frequent somatic mutations and copy-number amplifications, which were strongly associated with transcriptional dysregulation and inferior overall survival. Unsupervised clustering revealed two distinct subtypes: a metabolism-enriched cluster associated with favorable prognosis, and an immune- and stroma-enriched cluster characterized by abundant regulatory T-cell infiltration and adverse clinical outcomes. The RMP_Score robustly stratified patient survival across six independent cohorts, correlated with differential sensitivity to inhibitors targeting the JNK\/p38, PI3K\/mTOR, and WNT pathways, and accurately predicted clinical responses to anti-PD-L1 immunotherapy, with low RMP_Scores demonstrating superior responses. CES1 emerged as a robust predictor of poor survival and immunotherapy resistance, closely associated with tumor progression, extracellular matrix remodeling, and an immunosuppressive, fibroblast-rich TME. Functionally, CES1 silencing significantly attenuated bladder cancer cell viability, invasive capacity, and migratory potential in vitro.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings established an RNA modification-based framework for molecular classification and risk stratification in bladder cancer, and identified CES1 as a metabolically driven regulator of the TME with potential utility as a prognostic and predictive biomarker for immune checkpoint blockade.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-026-15897-4","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T07:26:51Z","timestamp":1774423611000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrative analysis of adenosine-related RNA modifications defines molecular subtypes of bladder cancer and identifies CES1 as a driver of tumor progression and immunotherapy resistance"],"prefix":"10.1186","volume":"26","author":[{"given":"Xingxing","family":"Huo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongfu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,25]]},"reference":[{"key":"15897_CR1","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.eururo.2016.06.010","volume":"71","author":"S Antoni","year":"2017","unstructured":"Antoni S, Ferlay J, Soerjomataram I, Znaor A, Jemal A, Bray F. Bladder cancer incidence and mortality: a global overview and recent trends. Eur Urol. 2017;71:96\u2013108.","journal-title":"Eur Urol"},{"key":"15897_CR2","doi-asserted-by":"publisher","first-page":"17022","DOI":"10.1038\/nrdp.2017.22","volume":"3","author":"O Sanli","year":"2017","unstructured":"Sanli O, Dobruch J, Knowles MA, Burger M, Alemozaffar M, Nielsen ME, et al. Bladder cancer. Nat Rev Dis Primers. 2017;3:17022.","journal-title":"Nat Rev Dis Primers"},{"key":"15897_CR3","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1016\/S0140-6736(16)30512-8","volume":"388","author":"AM Kamat","year":"2016","unstructured":"Kamat AM, Hahn NM, Efstathiou JA, Lerner SP, Malmstr\u00f6m PU, Choi W, et al. Bladder cancer. Lancet. 2016;388:2796\u2013810.","journal-title":"Lancet"},{"key":"15897_CR4","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.urolonc.2018.02.017","volume":"36","author":"F Audenet","year":"2018","unstructured":"Audenet F, Attalla K, Sfakianos JP. The evolution of bladder cancer genomics: what have we learned and how can we use it? Urol Oncol. 2018;36:313\u201320.","journal-title":"Urol Oncol"},{"key":"15897_CR5","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41420-025-02585-8","volume":"11","author":"WF Yang","year":"2025","unstructured":"Yang WF, Guo WM, Luo QT, Lu J, Tan ZK, Ye YC, et al. Transcription factor TCF3 promotes bladder cancer development via TMBIM6-Ca2+-dependent ferroptosis. Cell Death Discov. 2025;11:303. https:\/\/doi.org\/10.1038\/s41420-025-02585-8.","journal-title":"Cell Death Discov"},{"key":"15897_CR6","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/s41420-025-02506-9","volume":"11","author":"Z Song","year":"2025","unstructured":"Song Z, Gui S, Rao X, Zhang G, Cheng Y, Zeng T. TAZ\/NRF2 positive feedback loop contributes to proliferation in bladder cancer through antagonistic ferroptosis. Cell Death Discov. 2025;11:208. https:\/\/doi.org\/10.1038\/s41420-025-02506-9.","journal-title":"Cell Death Discov"},{"key":"15897_CR7","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/s41420-025-02546-1","volume":"11","author":"D Barnaba","year":"2025","unstructured":"Barnaba D, Franzese Canonico M, Helmer-Citterich M, Gandellini P, Melino G, Smirnov A, et al. LEADR, a p63 target, dampens interferon signalling in bladder cancer. Cell Death Discov. 2025;11:264. https:\/\/doi.org\/10.1038\/s41420-025-02546-1.","journal-title":"Cell Death Discov"},{"key":"15897_CR8","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1186\/s12967-025-07613-w","volume":"23","author":"J Huang","year":"2025","unstructured":"Huang J, Chen D, Ji G, Ma J, Zhao Z, Deng H. ERO1A promotes the proliferation, migration and invasion of bladder cancer through ALOX5 mediated activation of JAK-STAT signaling pathway. J Transl Med. 2025;23:1427. https:\/\/doi.org\/10.1186\/s12967-025-07613-w.","journal-title":"J Transl Med"},{"key":"15897_CR9","doi-asserted-by":"publisher","first-page":"101565","DOI":"10.1016\/j.gendis.2025.101565","volume":"12","author":"Q Shi","year":"2025","unstructured":"Shi Q, Pan X, Zhang S, Wu M, Xu M, Li YQ, et al. Menin facilitates the cell proliferation of bladder cancer via modulating the TFAP2C\/\u03b2-catenin axis. Genes Dis. 2025;12:101565. https:\/\/doi.org\/10.1016\/j.gendis.2025.101565.","journal-title":"Genes Dis"},{"key":"15897_CR10","doi-asserted-by":"publisher","first-page":"101578","DOI":"10.1016\/j.gendis.2025.101578","volume":"12","author":"Y Xiao","year":"2025","unstructured":"Xiao Y, Ju L, Wang G, Jin W, Peng H, Zhou Z, et al. Elucidating the pathogenesis of bladder cancer through single-cell chromatin accessibility and DNA methylation analysis. Genes Dis. 2025;12:101578. https:\/\/doi.org\/10.1016\/j.gendis.2025.101578.","journal-title":"Genes Dis"},{"key":"15897_CR11","doi-asserted-by":"publisher","first-page":"101760","DOI":"10.1016\/j.gendis.2025.101760","volume":"13","author":"L Liu","year":"2025","unstructured":"Liu L, Wan X, Liu S, Yu C, Xue H, Wang J, et al. Single-cell molecular communications and transcriptional regulatory dynamics of T cell immunotherapy in bladder cancer. Genes Dis. 2025;13:101760. https:\/\/doi.org\/10.1016\/j.gendis.2025.101760.","journal-title":"Genes Dis"},{"key":"15897_CR12","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12967-025-07534-8","volume":"24","author":"Z Wang","year":"2025","unstructured":"Wang Z, Miao J, Wang M, Ying Y, Zhang Z, Zeng S, et al. Single-cell and spatial atlas unveil tumor-specific microenvironment convergence and a prognosis-associated PLXDC1\u2009+\u2009myofibroblast population in metastatic bladder cancer. J Transl Med. 2025;24:88. https:\/\/doi.org\/10.1186\/s12967-025-07534-8.","journal-title":"J Transl Med"},{"key":"15897_CR13","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41420-025-02489-7","volume":"11","author":"A Turdo","year":"2025","unstructured":"Turdo A, Tulone G, Di Bella S, Porcelli G, D\u2019Accardo C, Gaggianesi M, et al. Heightened IDO1 levels predict Bacillus Calmette-Gu\u00e9rin failure in high-risk non-muscle-invasive bladder cancer patients. Cell Death Discov. 2025;11:203. https:\/\/doi.org\/10.1038\/s41420-025-02489-7.","journal-title":"Cell Death Discov"},{"key":"15897_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-026-07830-x","author":"DM Xu","year":"2026","unstructured":"Xu DM, Chen J, Lin SB, Xu TY, Zhan ZZ, Yang ZL, et al. ATIC facilitates the malignant progression of bladder cancer by modulating the AMPK-mTOR-S6K1 axis under folate reprogramming. J Transl Med. 2026. https:\/\/doi.org\/10.1186\/s12967-026-07830-x.","journal-title":"J Transl Med"},{"key":"15897_CR15","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s11934-018-0861-5","volume":"19","author":"SP Porten","year":"2018","unstructured":"Porten SP. Epigenetic alterations in bladder cancer. Curr Urol Rep. 2018;19:102.","journal-title":"Curr Urol Rep"},{"key":"15897_CR16","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s12013-013-9555-2","volume":"67","author":"H Akhavan-Niaki","year":"2013","unstructured":"Akhavan-Niaki H, Samadani AA. DNA methylation and cancer development: molecular mechanism. Cell Biochem Biophys. 2013;67:501\u201313.","journal-title":"Cell Biochem Biophys"},{"key":"15897_CR17","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/S0959-437X(02)00279-4","volume":"12","author":"SL Berger","year":"2002","unstructured":"Berger SL. Histone modifications in transcriptional regulation. Curr Opin Genet Dev. 2002;12:142\u20138.","journal-title":"Curr Opin Genet Dev"},{"key":"15897_CR18","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.cell.2007.05.009","volume":"129","author":"A Barski","year":"2007","unstructured":"Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z, et al. High-resolution profiling of histone methylations in the human genome. Cell. 2007;129:823\u201337.","journal-title":"Cell"},{"key":"15897_CR19","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.tig.2017.04.003","volume":"33","author":"JY Roignant","year":"2017","unstructured":"Roignant JY, Soller M. m6A in mRNA: an ancient mechanism for fine-tuning gene expression. Trends Genet. 2017;33:380\u201390.","journal-title":"Trends Genet"},{"key":"15897_CR20","first-page":"765","volume":"25","author":"D Dominissini","year":"2018","unstructured":"Dominissini D, Rechavi G. Epitranscriptome regulation. Nat Struct Mol Biol. 2018;25:765\u20136.","journal-title":"Nat Struct Mol Biol"},{"key":"15897_CR21","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1002\/wrna.79","volume":"2","author":"Y Motorin","year":"2011","unstructured":"Motorin Y, Helm M. RNA nucleotide methylation. Wiley Interdiscip Rev RNA. 2011;2:611\u201331.","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"15897_CR22","doi-asserted-by":"publisher","first-page":"7511","DOI":"10.1093\/nar\/gkw551","volume":"44","author":"A Ramanathan","year":"2016","unstructured":"Ramanathan A, Robb GB, Chan SH. mRNA capping: biological functions and applications. Nucleic Acids Res. 2016;44:7511\u201326.","journal-title":"Nucleic Acids Res"},{"key":"15897_CR23","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0079-6603(08)60143-9","volume":"53","author":"PF Agris","year":"1996","unstructured":"Agris PF. The importance of being modified: roles of modified nucleosides and Mg2\u2009+\u2009in RNA structure and function. Prog Nucleic Acid Res Mol Biol. 1996;53:79\u2013129.","journal-title":"Prog Nucleic Acid Res Mol Biol"},{"key":"15897_CR24","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.molcel.2017.12.006","volume":"69","author":"JF Xiang","year":"2018","unstructured":"Xiang JF, Yang Q, Liu CX, Wu M, Chen LL, Yang L. N6-methyladenosines modulate A-to-I RNA editing. Mol Cell. 2018;69:126\u2013e1356.","journal-title":"Mol Cell"},{"key":"15897_CR25","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/nature19342","volume":"537","author":"DP Patil","year":"2016","unstructured":"Patil DP, Chen CK, Pickering BF, Chow A, Jackson C, Guttman M, et al. m6A RNA methylation promotes XIST-mediated transcriptional repression. Nature. 2016;537:369\u201373.","journal-title":"Nature"},{"key":"15897_CR26","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1101\/gad.262766.115","volume":"29","author":"Y Yue","year":"2015","unstructured":"Yue Y, Liu J, He C. RNA N6-methyladenosine methylation in post-transcriptional gene expression regulation. Genes Dev. 2015;29:1343\u201355.","journal-title":"Genes Dev"},{"key":"15897_CR27","doi-asserted-by":"publisher","first-page":"160003","DOI":"10.1098\/rsob.160003","volume":"6","author":"G Cao","year":"2016","unstructured":"Cao G, Li HB, Yin Z, Flavell RA. Recent advances in dynamic m6A RNA modification. Open Biol. 2016;6:160003.","journal-title":"Open Biol"},{"key":"15897_CR28","doi-asserted-by":"publisher","first-page":"110098","DOI":"10.1016\/j.biopha.2020.110098","volume":"127","author":"S Liu","year":"2020","unstructured":"Liu S, Li Q, Chen K, Zhang Q, Li G, Zhuo L, et al. The emerging molecular mechanism of m6A modulators in tumorigenesis and cancer progression. Biomed Pharmacother. 2020;127:110098.","journal-title":"Biomed Pharmacother"},{"key":"15897_CR29","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1038\/s41556-018-0174-4","volume":"20","author":"J Liu","year":"2018","unstructured":"Liu J, Eckert MA. m6A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer. Nat Cell Biol. 2018;20:1074\u201383.","journal-title":"Nat Cell Biol"},{"key":"15897_CR30","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.molcel.2016.03.021","volume":"62","author":"S Lin","year":"2016","unstructured":"Lin S, Choe J, Du P, Triboulet R, Gregory RI. The m6A methyltransferase METTL3 promotes translation in human cancer cells. Mol Cell. 2016;62:335\u201345.","journal-title":"Mol Cell"},{"key":"15897_CR31","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1038\/s41467-019-09865-9","volume":"10","author":"X Lin","year":"2019","unstructured":"Lin X, Chai G, Wu Y, Li J, Chen F, Liu J, et al. RNA m6A methylation regulates the epithelial mesenchymal transition of cancer cells and translation of Snail. Nat Commun. 2019;10:2065.","journal-title":"Nat Commun"},{"key":"15897_CR32","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-019-0916-x","volume":"566","author":"D Han","year":"2019","unstructured":"Han D, Liu J, Chen C, Dong L, Liu Y, Chang R, et al. Anti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cells. Nature. 2019;566:270\u20134.","journal-title":"Nature"},{"key":"15897_CR33","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nchembio.2040","volume":"12","author":"X Li","year":"2016","unstructured":"Li X, Xiong X, Wang K, Wang L, Shu X, Ma S, et al. Transcriptome-wide mapping reveals reversible and dynamic N1-methyladenosine methylome. Nat Chem Biol. 2016;12:311\u20136.","journal-title":"Nat Chem Biol"},{"key":"15897_CR34","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/nature16998","volume":"530","author":"D Dominissini","year":"2016","unstructured":"Dominissini D, Nachtergaele S, Moshitch-Moshkovitz S, Peer E, Kol N, Ben-Haim MS, et al. The dynamic N1-methyladenosine methylome in eukaryotic messenger RNA. Nature. 2016;530:441\u20136.","journal-title":"Nature"},{"key":"15897_CR35","doi-asserted-by":"publisher","first-page":"3894","DOI":"10.12659\/MSM.913556","volume":"25","author":"Y Wang","year":"2019","unstructured":"Wang Y, Huang Q, Deng T, Li BH, Ren XQ. Clinical significance of TRMT6 in hepatocellular carcinoma: a bioinformatics-based study. Med Sci Monit. 2019;25:3894\u2013901.","journal-title":"Med Sci Monit"},{"key":"15897_CR36","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.tranon.2019.06.007","volume":"12","author":"Y Zhao","year":"2019","unstructured":"Zhao Y, Zhao Q, Kaboli PJ, Shen J, Li M, Wu X, et al. m1A regulated genes modulate PI3K\/AKT\/mTOR and ErbB pathways in gastrointestinal cancer. Transl Oncol. 2019;12:1323\u201333.","journal-title":"Transl Oncol"},{"key":"15897_CR37","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.molcel.2011.08.017","volume":"43","author":"DC Di Giammartino","year":"2011","unstructured":"Di Giammartino DC, Nishida K, Manley JL. Mechanisms and consequences of alternative polyadenylation. Mol Cell. 2011;43:853\u201366.","journal-title":"Mol Cell"},{"key":"15897_CR38","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.cell.2009.06.016","volume":"138","author":"C Mayr","year":"2009","unstructured":"Mayr C, Bartel DP. Widespread shortening of 3\u2032UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells. Cell. 2009;138:673\u201384.","journal-title":"Cell"},{"key":"15897_CR39","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.ccell.2015.08.013","volume":"28","author":"L Han","year":"2015","unstructured":"Han L, Diao L, Yu S, Xu X, Li J, Zhang R, et al. The genomic landscape and clinical relevance of A-to-I RNA editing in human cancers. Cancer Cell. 2015;28:515\u201328.","journal-title":"Cancer Cell"},{"key":"15897_CR40","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.ccell.2018.03.026","volume":"33","author":"X Peng","year":"2018","unstructured":"Peng X, Xu X, Wang Y, Hawke DH, Yu S, Han L, et al. A-to-I RNA editing contributes to proteomic diversity in cancer. Cancer Cell. 2018;33:817\u2013e8287.","journal-title":"Cancer Cell"},{"key":"15897_CR41","doi-asserted-by":"publisher","first-page":"5642","DOI":"10.1158\/1078-0432.CCR-16-0066","volume":"22","author":"DA Braun","year":"2016","unstructured":"Braun DA, Burke KP, Van Allen EM. Genomic approaches to understanding response and resistance to immunotherapy. Clin Cancer Res. 2016;22:5642\u201350.","journal-title":"Clin Cancer Res"},{"key":"15897_CR42","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nature21349","volume":"541","author":"DS Chen","year":"2017","unstructured":"Chen DS, Mellman I. Elements of cancer immunity and the cancer-immune set point. Nature. 2017;541:321\u201330.","journal-title":"Nature"},{"key":"15897_CR43","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1038\/s41467-019-09903-6","volume":"10","author":"H Wang","year":"2019","unstructured":"Wang H, Hu X, Huang M, Liu J, Gu Y, Ma L, et al. Mettl3-mediated mRNA m6A methylation promotes dendritic cell activation. Nat Commun. 2019;10:1898.","journal-title":"Nat Commun"},{"key":"15897_CR44","doi-asserted-by":"publisher","first-page":"188522","DOI":"10.1016\/j.bbcan.2021.188522","volume":"1875","author":"M Li","year":"2021","unstructured":"Li M, Zha X, Wang S. The role of N6-methyladenosine mRNA in the tumor microenvironment. Biochim Biophys Acta Rev Cancer. 2021;1875:188522.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"15897_CR45","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12943-020-01207-4","volume":"19","author":"Y Chen","year":"2020","unstructured":"Chen Y, Lin Y, Shu Y, He J, Gao W. Interaction between N6-methyladenosine (m6A) modification and noncoding RNAs in cancer. Mol Cancer. 2020;19:94.","journal-title":"Mol Cancer"},{"key":"15897_CR46","doi-asserted-by":"publisher","first-page":"e104514","DOI":"10.15252\/embj.2020104514","volume":"39","author":"L Wang","year":"2020","unstructured":"Wang L, Hui H, Agrawal K, Kang Y, Li N, Tang R, et al. m6A RNA methyltransferases METTL3\/14 regulate immune responses to anti-PD-1 therapy. EMBO J. 2020;39:e104514.","journal-title":"EMBO J"},{"key":"15897_CR47","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1038\/s41467-021-21514-8","volume":"12","author":"H Yin","year":"2021","unstructured":"Yin H, Zhang X, Yang P, Zhang X, Peng Y, Li D, et al. RNA m6A methylation orchestrates cancer growth and metastasis via macrophage reprogramming. Nat Commun. 2021;12:1394.","journal-title":"Nat Commun"},{"key":"15897_CR48","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12935-025-04133-x","volume":"26","author":"H Dai","year":"2026","unstructured":"Dai H, Zhang X, Yin L, Chen H, Liu K, Li J, et al. Integrating machine learning and multi-omics analysis to explore Treg-associated programmed cell death features in clear cell renal cell carcinoma. Cancer Cell Int. 2026;26:15. https:\/\/doi.org\/10.1186\/s12935-025-04133-x.","journal-title":"Cancer Cell Int"},{"key":"15897_CR49","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13008-025-00172-y","volume":"20","author":"H Dai","year":"2025","unstructured":"Dai H, Wang X, Wu Q, Tan Y, Shen H, Gu Y, et al. Integrating genetic crosstalk between atherosclerosis and lung adenocarcinoma to advance precision diagnosis and treatment. Cell Div. 2025;20:27. https:\/\/doi.org\/10.1186\/s13008-025-00172-y.","journal-title":"Cell Div"},{"key":"15897_CR50","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13062-025-00650-x","volume":"20","author":"H Dai","year":"2025","unstructured":"Dai H, Yu Z, Zhao Y, Jiang K, Hang Z, Huang X, et al. Integrating machine learning models with multi-omics analysis to decipher the prognostic significance of mitotic catastrophe heterogeneity in bladder cancer. Biol Direct. 2025;20:56. https:\/\/doi.org\/10.1186\/s13062-025-00650-x.","journal-title":"Biol Direct"},{"key":"15897_CR51","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s41065-025-00409-4","volume":"162","author":"H Dai","year":"2025","unstructured":"Dai H, Zhang X, Zhao Y, Nie J, Hang Z, Huang X, et al. ADME gene-driven prognostic model for bladder cancer: a breakthrough in predicting survival and personalized treatment. Hereditas. 2025;162:42. https:\/\/doi.org\/10.1186\/s41065-025-00409-4.","journal-title":"Hereditas"},{"key":"15897_CR52","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12894-025-01914-4","volume":"25","author":"H Dai","year":"2025","unstructured":"Dai H, Zhao K, Zhao Y, Jiang K, Hang Z, Huang X, et al. Machine learning model in multi-omics perspective demystifies the prognostic significance of crotonylation heterogeneity in clear cell renal cell carcinoma. BMC Urol. 2025;25:229. https:\/\/doi.org\/10.1186\/s12894-025-01914-4.","journal-title":"BMC Urol"},{"key":"15897_CR53","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","volume":"554","author":"S Mariathasan","year":"2018","unstructured":"Mariathasan S, Turley SJ, Nickles D, Castiglioni A, Yuen K, Wang Y, et al. TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature. 2018;554:544\u20139.","journal-title":"Nature"},{"key":"15897_CR54","doi-asserted-by":"publisher","first-page":"D1420","DOI":"10.1093\/nar\/gkaa1020","volume":"49","author":"D Sun","year":"2021","unstructured":"Sun D, Wang J, Han Y, Dong X, Ge J, Zheng R, et al. TISCH: a comprehensive web resource enabling interactive single-cell transcriptome visualization of tumor microenvironment. Nucleic Acids Res. 2021;49:D1420\u201330.","journal-title":"Nucleic Acids Res"},{"key":"15897_CR55","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1158\/1078-0432.CCR-15-0876","volume":"22","author":"MP Mak","year":"2016","unstructured":"Mak MP, Tong P, Diao L, Cardnell RJ, Gibbons DL, William WN, et al. A patient-derived, pan-cancer EMT signature identifies global molecular alterations and immune target enrichment following epithelial-to-mesenchymal transition. Clin Cancer Res. 2016;22:609\u201320.","journal-title":"Clin Cancer Res"},{"key":"15897_CR56","doi-asserted-by":"publisher","first-page":"5312","DOI":"10.1038\/s41467-025-59888-8","volume":"16","author":"H Yang","year":"2025","unstructured":"Yang H, Song H, Yip E, Gilpatrick T, Chang K, Allegakoen P, et al. Bladder cancer variants share aggressive features including a CA125\u2009+\u2009cell state and targetable TM4SF1 expression. Nat Commun. 2025;16:5312.","journal-title":"Nat Commun"},{"key":"15897_CR57","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.canlet.2017.11.015","volume":"414","author":"R Cao","year":"2018","unstructured":"Cao R, Wang G, Qian K, Chen L, Ju L, Qian G, et al. TM4SF1 regulates apoptosis, cell cycle and ROS metabolism via the PPAR\u03b3-SIRT1 feedback loop in human bladder cancer cells. Cancer Lett. 2018;414:278\u201393.","journal-title":"Cancer Lett"},{"key":"15897_CR58","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Mart\u00ednez E, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612.","journal-title":"Nat Commun"},{"key":"15897_CR59","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-1-4939-7493-1_12","volume":"1711","author":"B Chen","year":"2018","unstructured":"Chen B, Khodadoust MS, Liu CL, Newman AM, Alizadeh AA. Profiling tumor infiltrating immune cells with CIBERSORT. Methods Mol Biol. 2018;1711:243\u201359.","journal-title":"Methods Mol Biol"},{"key":"15897_CR60","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.eururo.2019.09.006","volume":"77","author":"A Kamoun","year":"2020","unstructured":"Kamoun A, de Reyni\u00e8s A, Allory Y, et al. A consensus molecular classification of muscle-invasive bladder cancer. Eur Urol. 2020;77:420\u201333. https:\/\/doi.org\/10.1016\/j.eururo.2019.09.006.","journal-title":"Eur Urol"},{"key":"15897_CR61","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.cell.2017.09.007","volume":"171","author":"AG Robertson","year":"2017","unstructured":"Robertson AG, Kim J, Al Ahmadie H, et al. Comprehensive molecular characterization of muscle-invasive bladder cancer. Cell. 2017;171:540\u2013e55625. https:\/\/doi.org\/10.1016\/j.cell.2017.09.007.","journal-title":"Cell"},{"key":"15897_CR62","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41571-023-00774-x","volume":"20","author":"X Deng","year":"2023","unstructured":"Deng X, Qing Y, Horne D, Huang H, Chen J. The roles and implications of RNA m6A modification in cancer. Nat Rev Clin Oncol. 2023;20:507\u201326.","journal-title":"Nat Rev Clin Oncol"},{"key":"15897_CR63","doi-asserted-by":"publisher","first-page":"3667","DOI":"10.1038\/s41388-019-0683-z","volume":"38","author":"M Cheng","year":"2019","unstructured":"Cheng M, Sheng L, Gao Q, et al. The m6A methyltransferase METTL3 promotes bladder cancer progression via AFF4\/NF-\u03baB\/MYC signaling network. Oncogene. 2019;38:3667\u201380.","journal-title":"Oncogene"},{"key":"15897_CR64","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1158\/0008-5472.CAN-21-1323","volume":"82","author":"Z Ni","year":"2022","unstructured":"Ni Z, Sun P, Zheng J, et al. JNK signaling promotes bladder cancer immune escape by regulating METTL3-mediated m6A modification of PD-L1 mRNA. Cancer Res. 2022;82:1789\u2013802. https:\/\/doi.org\/10.1158\/0008-5472.CAN-21-1323.","journal-title":"Cancer Res"},{"key":"15897_CR65","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s10495-023-01817-5","volume":"28","author":"K Wang","year":"2023","unstructured":"Wang K, Wang G, Li G, et al. m6A writer WTAP targets NRF2 to accelerate bladder cancer malignancy via m6A-dependent ferroptosis regulation. Apoptosis. 2023;28:627\u201338. https:\/\/doi.org\/10.1007\/s10495-023-01817-5.","journal-title":"Apoptosis"},{"key":"15897_CR66","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1038\/s41467-022-29790-8","volume":"13","author":"Z Su","year":"2022","unstructured":"Su Z, Monshaugen I, Wilson B, Wang F, Klungland A, Ougland R, et al. TRMT6\/61A-dependent base methylation of tRNA-derived fragments regulates gene-silencing activity and the unfolded protein response in bladder cancer. Nat Commun. 2022;13:2165. https:\/\/doi.org\/10.1038\/s41467-022-29790-8.","journal-title":"Nat Commun"},{"key":"15897_CR67","doi-asserted-by":"publisher","first-page":"1334112","DOI":"10.3389\/fonc.2023.1334112","volume":"13","author":"I Monshaugen","year":"2024","unstructured":"Monshaugen I, Luna L, Rhodes J, et al. Depletion of the m1A writer TRMT6\/TRMT61A reduces proliferation and resistance against cellular stress in bladder cancer. Front Oncol. 2024;13:1334112. https:\/\/doi.org\/10.3389\/fonc.2023.1334112.","journal-title":"Front Oncol"},{"key":"15897_CR68","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.omtn.2020.10.031","volume":"23","author":"H Yu","year":"2020","unstructured":"Yu H, Yang X, Tang J, Si S, Zhou Z, Lu J, et al. ALKBH5 inhibited cell proliferation and sensitized bladder cancer cells to cisplatin by m6A-CK2\u03b1-mediated glycolysis. Mol Ther Nucleic Acids. 2020;23:27\u201341. https:\/\/doi.org\/10.1016\/j.omtn.2020.10.031.","journal-title":"Mol Ther Nucleic Acids"},{"key":"15897_CR69","doi-asserted-by":"publisher","first-page":"12867","DOI":"10.1007\/s00432-023-05164-5","volume":"149","author":"C Shen","year":"2023","unstructured":"Shen C, Liu J, Jiao W, Zhang X, Zhao X, Yang X, et al. A feed-forward loop based on aerobic glycolysis and TGF-\u03b2 between tumor-associated macrophages and bladder cancer cells promoted malignant progression and immune escape. J Cancer Res Clin Oncol. 2023;149:12867\u201380. https:\/\/doi.org\/10.1007\/s00432-023-05164-5.","journal-title":"J Cancer Res Clin Oncol"},{"key":"15897_CR70","doi-asserted-by":"publisher","first-page":"e011108","DOI":"10.1136\/jitc-2024-011108","volume":"13","author":"Y Tong","year":"2025","unstructured":"Tong Y, Chen Z, Wu J, Huang Q, He Y, Shang H, et al. METTL3 promotes an immunosuppressive microenvironment in bladder cancer via m6A-dependent CXCL5\/CCL5 regulation. J Immunother Cancer. 2025;13:e011108. https:\/\/doi.org\/10.1136\/jitc-2024-011108.","journal-title":"J Immunother Cancer"},{"key":"15897_CR71","doi-asserted-by":"publisher","first-page":"796","DOI":"10.21147\/j.issn.1000-9604.2025.05.11","volume":"37","author":"W Xia","year":"2025","unstructured":"Xia W, Liu J, Chen R, Feng J, Wu L, Wang Y, et al. Molecular subtypes and prognostic signature rooted in disulfidptosis highlight tumor microenvironment in lung adenocarcinoma. Chin J Cancer Res. 2025;37:796\u2013820. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2025.05.11.","journal-title":"Chin J Cancer Res"},{"key":"15897_CR72","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/s41746-025-02172-2","volume":"8","author":"Z Gong","year":"2025","unstructured":"Gong Z, Du M, Li Y, Ye B, Huang Y, Gong H, et al. Machine learning identifies TIME subtypes linking EGFR mutations and immune states in lung adenocarcinoma. NPJ Digit Med. 2025;8:796. https:\/\/doi.org\/10.1038\/s41746-025-02172-2.","journal-title":"NPJ Digit Med"},{"key":"15897_CR73","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.21147\/j.issn.1000-9604.2025.06.11","volume":"37","author":"P Zhang","year":"2025","unstructured":"Zhang P, Liang X, Ye B, Wang X, Wang Y, Gong Z, et al. Metabolic reprogramming signature predicts immunotherapy efficacy in lung adenocarcinoma: targeting SLC25A1 to overcome immune resistance. Chin J Cancer Res. 2025;37:1000\u201319. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2025.06.11.","journal-title":"Chin J Cancer Res"},{"key":"15897_CR74","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1111\/cas.14422","volume":"111","author":"S Suzuki","year":"2020","unstructured":"Suzuki S, Ogawa T, Sano R, Takahara T, Inukai D, Akira S, et al. Immune-checkpoint molecules on regulatory T cells as a potential therapeutic target in head and neck squamous cell cancers. Cancer Sci. 2020;111:1943\u201357.","journal-title":"Cancer Sci"},{"key":"15897_CR75","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.3390\/cells13211779","volume":"13","author":"C Klein","year":"2024","unstructured":"Klein C, Mebroukine S, Mad\u00e9ry M, et al. Myeloid-derived suppressor cells in bladder cancer: an emerging target. Cells. 2024;13:1779. https:\/\/doi.org\/10.3390\/cells13211779.","journal-title":"Cells"},{"key":"15897_CR76","doi-asserted-by":"publisher","first-page":"4712","DOI":"10.3390\/cancers13184712","volume":"13","author":"MM Leblond","year":"2021","unstructured":"Leblond MM, Zdimerova H, Desponds E, Verdeil G. Tumor-associated macrophages in bladder cancer: biological role, impact on therapeutic response and perspectives for immunotherapy. Cancers (Basel). 2021;13:4712. https:\/\/doi.org\/10.3390\/cancers13184712.","journal-title":"Cancers (Basel)"},{"key":"15897_CR77","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.3390\/biomedicines9111500","volume":"9","author":"HW Choi","year":"2021","unstructured":"Choi HW, Naskar M, Seo HK, Lee HW. Tumor-associated mast cells in urothelial bladder cancer: optimizing immuno-oncology. Biomedicines. 2021;9:1500. https:\/\/doi.org\/10.3390\/biomedicines9111500.","journal-title":"Biomedicines"},{"key":"15897_CR78","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1038\/s41467-021-23086-z","volume":"12","author":"S Shinde-Jadhav","year":"2021","unstructured":"Shinde-Jadhav S, Mansure JJ, Rayes RF, et al. Role of neutrophil extracellular traps in radiation resistance of invasive bladder cancer. Nat Commun. 2021;12:2776. https:\/\/doi.org\/10.1038\/s41467-021-23086-z.","journal-title":"Nat Commun"},{"key":"15897_CR79","doi-asserted-by":"publisher","first-page":"e012736","DOI":"10.1136\/jitc-2025-012736","volume":"13","author":"T Cai","year":"2025","unstructured":"Cai T, Feng T, Zhang W, et al. Neutrophil extracellular traps-STC1 positive feedback loop promotes immune evasion and metastasis in bladder cancer. J Immunother Cancer. 2025;13:e012736. https:\/\/doi.org\/10.1136\/jitc-2025-012736.","journal-title":"J Immunother Cancer"},{"key":"15897_CR80","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.ccell.2020.10.010","volume":"38","author":"S Bhatt","year":"2020","unstructured":"Bhatt S, Pioso MS, Olesinski EA, Yilma B, Ryan JA, Mashaka T, et al. Reduced mitochondrial apoptotic priming drives resistance to BH3 mimetics in acute myeloid leukemia. Cancer Cell. 2020;38:872\u2013e8906. https:\/\/doi.org\/10.1016\/j.ccell.2020.10.010.","journal-title":"Cancer Cell"},{"key":"15897_CR81","doi-asserted-by":"publisher","first-page":"9859","DOI":"10.3390\/ijms26209859","volume":"26","author":"N Mukherjee","year":"2025","unstructured":"Mukherjee N, Sheetz J, Shellman YG. Targeting the BCL2 family: advances and challenges in BH3 mimetic-based therapies. Int J Mol Sci. 2025;26:9859. https:\/\/doi.org\/10.3390\/ijms26209859.","journal-title":"Int J Mol Sci"},{"key":"15897_CR82","doi-asserted-by":"publisher","first-page":"103972","DOI":"10.1016\/j.esmoop.2024.103972","volume":"9","author":"JE Rosenberg","year":"2024","unstructured":"Rosenberg JE, Galsky MD, Powles T, et al. Atezolizumab monotherapy for metastatic urothelial carcinoma: final analysis from the phase II IMvigor210 trial. ESMO Open. 2024;9:103972. https:\/\/doi.org\/10.1016\/j.esmoop.2024.103972.","journal-title":"ESMO Open"},{"key":"15897_CR83","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1056\/NEJMoa1817323","volume":"381","author":"AO Siefker-Radtke","year":"2019","unstructured":"Siefker-Radtke AO, Necchi A, Park SH, et al. Erdafitinib in locally advanced or metastatic urothelial carcinoma. N Engl J Med. 2019;381:338\u201348. https:\/\/doi.org\/10.1056\/NEJMoa1817323.","journal-title":"N Engl J Med"},{"key":"15897_CR84","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1056\/NEJMoa2308849","volume":"389","author":"Y Loriot","year":"2023","unstructured":"Loriot Y, et al. Erdafitinib or chemotherapy in advanced or metastatic urothelial carcinoma. N Engl J Med. 2023;389:1961\u201371. https:\/\/doi.org\/10.1056\/NEJMoa2308849.","journal-title":"N Engl J Med"},{"key":"15897_CR85","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00335-010-9284-4","volume":"21","author":"RS Holmes","year":"2010","unstructured":"Holmes RS, et al. Recommended nomenclature for five mammalian carboxylesterase gene families: human, mouse, and rat genes and proteins. Mamm Genome. 2010;21:427\u201341.","journal-title":"Mamm Genome"},{"key":"15897_CR86","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s13238-017-0437-z","volume":"9","author":"J Lian","year":"2018","unstructured":"Lian J, Nelson R, Lehner R. Carboxylesterases in lipid metabolism: from mouse to human. Protein Cell. 2018;9:178\u201395.","journal-title":"Protein Cell"},{"key":"15897_CR87","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.2337\/db18-1210","volume":"68","author":"L Yang","year":"2019","unstructured":"Yang L, Li X, Tang H, Gao Z, Zhang K, Sun K. A unique role of carboxylesterase 3 (Ces3) in \u03b2-adrenergic signaling-stimulated thermogenesis. Diabetes. 2019;68:1178\u201396.","journal-title":"Diabetes"},{"key":"15897_CR88","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.apsb.2022.10.017","volume":"13","author":"C Gan","year":"2023","unstructured":"Gan C, Wang J, Mart\u00ednez-Ch\u00e1vez A, Hillebrand M, de Vries N, Beukers J, et al. Carboxylesterase 1 family knockout alters drug disposition and lipid metabolism. Acta Pharm Sin B. 2023;13:618\u201331. https:\/\/doi.org\/10.1016\/j.apsb.2022.10.017.","journal-title":"Acta Pharm Sin B"},{"key":"15897_CR89","doi-asserted-by":"publisher","first-page":"189190","DOI":"10.1016\/j.bbcan.2024.189190","volume":"1879","author":"B Xia","year":"2024","unstructured":"Xia B, Qiu L, Yue J, Si J, Zhang H. The metabolic crosstalk of cancer-associated fibroblasts and tumor cells: recent advances and future perspectives. Biochim Biophys Acta Rev Cancer. 2024;1879:189190. https:\/\/doi.org\/10.1016\/j.bbcan.2024.189190.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"15897_CR90","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13045-024-01600-2","volume":"17","author":"F Zhang","year":"2024","unstructured":"Zhang F, Ma Y, Li D, Wei J, Chen K, Zhang E, et al. Cancer associated fibroblasts and metabolic reprogramming: unraveling the intricate crosstalk in tumor evolution. J Hematol Oncol. 2024;17:80. https:\/\/doi.org\/10.1186\/s13045-024-01600-2.","journal-title":"J Hematol Oncol"},{"key":"15897_CR91","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s11033-025-11283-8","volume":"53","author":"M Yin","year":"2025","unstructured":"Yin M, Li X, Zhang S, Xie SA. The interplay between extracellular matrix remodeling and cellular lipid metabolic reprogramming in cancer: a review. Mol Biol Rep. 2025;53:145. https:\/\/doi.org\/10.1007\/s11033-025-11283-8.","journal-title":"Mol Biol Rep"},{"key":"15897_CR92","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/s41419-025-08222-7","volume":"16","author":"Y Tao","year":"2025","unstructured":"Tao Y, Huang J, Hou J, Hu Z, Zhang T, Mo Z, et al. Matrix stiffness maintains bladder cancer stemness via integrin-nuclear skeleton axis. Cell Death Dis. 2025;16:887. https:\/\/doi.org\/10.1038\/s41419-025-08222-7.","journal-title":"Cell Death Dis"},{"key":"15897_CR93","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s40164-025-00647-2","volume":"14","author":"M Zhang","year":"2025","unstructured":"Zhang M, Zhang B. Extracellular matrix stiffness: mechanisms in tumor progression and therapeutic potential in cancer. Exp Hematol Oncol. 2025;14:54. https:\/\/doi.org\/10.1186\/s40164-025-00647-2.","journal-title":"Exp Hematol Oncol"},{"key":"15897_CR94","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41420-025-02536-3","volume":"11","author":"Z Wang","year":"2025","unstructured":"Wang Z, Sun H, Zhu S, Wang F, Li Q, Zhou J. RGS3 acts as a tumor promoter by facilitating the regulation of the TGF-\u03b2 signaling pathway and promoting EMT in ovarian cancer. Cell Death Discov. 2025;11:262. https:\/\/doi.org\/10.1038\/s41420-025-02536-3.","journal-title":"Cell Death Discov"},{"key":"15897_CR95","doi-asserted-by":"publisher","first-page":"101771","DOI":"10.1016\/j.gendis.2025.101771","volume":"13","author":"C Liu","year":"2025","unstructured":"Liu C, Wang S, Zhang X, Han Y, Tan M, Fan J, et al. The biomechanical signature of tumor invasion. Genes Dis. 2025;13:101771. https:\/\/doi.org\/10.1016\/j.gendis.2025.101771.","journal-title":"Genes Dis"},{"key":"15897_CR96","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/s41420-025-02503-y","volume":"11","author":"DM Xu","year":"2025","unstructured":"Xu DM, Chen LX, Xue T, Zhuang XY, Wei LC, Han H, et al. Decoding the impact of MMP1\u2009+\u2009malignant subsets on tumor-immune interactions: insights from single-cell and spatial transcriptomics. Cell Death Discov. 2025;11:244. https:\/\/doi.org\/10.1038\/s41420-025-02503-y.","journal-title":"Cell Death Discov"},{"key":"15897_CR97","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1186\/s12967-025-06596-y","volume":"23","author":"Q Wang","year":"2025","unstructured":"Wang Q, Feng W, Tan Y, Qiao J, Liu H, Liu Q, et al. Antiphospholipid antibodies inhibit the migration and invasion of trophoblast cells by suppressing the JNK\/C-Jun\/MMP1 signaling pathway. J Transl Med. 2025;23:581. https:\/\/doi.org\/10.1186\/s12967-025-06596-y.","journal-title":"J Transl Med"},{"key":"15897_CR98","doi-asserted-by":"publisher","first-page":"101529","DOI":"10.1016\/j.gendis.2025.101529","volume":"12","author":"S Tian","year":"2025","unstructured":"Tian S, Chen X, Li J. Zinc finger transcription factor ZNF24 inhibits colorectal cancer growth and metastasis by suppressing MMP2 transcription. Genes Dis. 2025;12:101529. https:\/\/doi.org\/10.1016\/j.gendis.2025.101529.","journal-title":"Genes Dis"},{"key":"15897_CR99","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41420-024-01962-z","volume":"10","author":"P Xing","year":"2024","unstructured":"Xing P, Liu H, Xiao W, Zhang G, Zhang C, Liao Z, et al. The fusion gene LRP1-SNRNP25 drives invasion and migration by activating the pJNK\/37LRP\/MMP2 signaling pathway in osteosarcoma. Cell Death Discov. 2024;10:198. https:\/\/doi.org\/10.1038\/s41420-024-01962-z.","journal-title":"Cell Death Discov"},{"key":"15897_CR100","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1186\/s12967-025-06526-y","volume":"23","author":"Z Hao","year":"2025","unstructured":"Hao Z, Zhang M, Du Y, Liu J, Zeng G, Li H, et al. Invadopodia in cancer metastasis: dynamics, regulation, and targeted therapies. J Transl Med. 2025;23:548. https:\/\/doi.org\/10.1186\/s12967-025-06526-y.","journal-title":"J Transl Med"},{"key":"15897_CR101","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1186\/s12967-025-06328-2","volume":"23","author":"Y Li","year":"2025","unstructured":"Li Y, Wang H, Mao D, Che X, Chen Y, Liu Y. Understanding pre-metastatic niche formation: implications for colorectal cancer liver metastasis. J Transl Med. 2025;23:340. https:\/\/doi.org\/10.1186\/s12967-025-06328-2.","journal-title":"J Transl Med"},{"key":"15897_CR102","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/ni.3366","volume":"17","author":"M Nomura","year":"2016","unstructured":"Nomura M, Liu J, Rovira II, Gonzalez-Hurtado E, Lee J, Wolfgang MJ, et al. Fatty acid oxidation in macrophage polarization. Nat Immunol. 2016;17:216\u20137.","journal-title":"Nat Immunol"},{"key":"15897_CR103","doi-asserted-by":"publisher","first-page":"104881","DOI":"10.1016\/j.critrevonc.2025.104881","volume":"215","author":"X Feng","year":"2025","unstructured":"Feng X, Zhang J, Yu B, An W, Jin X. Lipid metabolic reprogramming in tumor-associated macrophages: a key driver of functional polarization and tumor immunomodulation. Crit Rev Oncol Hematol. 2025;215:104881. https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104881.","journal-title":"Crit Rev Oncol Hematol"},{"key":"15897_CR104","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.3390\/biomedicines13051145","volume":"13","author":"F Liu","year":"2025","unstructured":"Liu F, Li K, Zhu Q. Targeting metabolic reprogramming in bladder cancer immunotherapy: a precision medicine approach. Biomedicines. 2025;13:1145. https:\/\/doi.org\/10.3390\/biomedicines13051145.","journal-title":"Biomedicines"},{"key":"15897_CR105","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1093\/jimmun\/vkae023","volume":"214","author":"M Snyder","year":"2025","unstructured":"Snyder M, Wang Z, Lara B, Fimbres J, Pichardo T, Mazzilli S, et al. The aryl hydrocarbon receptor controls IFN-\u03b3-induced immune checkpoints PD-L1 and IDO via the JAK\/STAT pathway in lung adenocarcinoma. J Immunol. 2025;214:413\u201332. https:\/\/doi.org\/10.1093\/jimmun\/vkae023.","journal-title":"J Immunol"},{"key":"15897_CR106","doi-asserted-by":"publisher","first-page":"1230135","DOI":"10.3389\/fimmu.2023.1230135","volume":"14","author":"C Feng","year":"2023","unstructured":"Feng C, Zhang L, Chang X, Qin D, Zhang T. Regulation of post-translational modification of PD-L1 and advances in tumor immunotherapy. Front Immunol. 2023;14:1230135. https:\/\/doi.org\/10.3389\/fimmu.2023.1230135.","journal-title":"Front Immunol"},{"key":"15897_CR107","doi-asserted-by":"publisher","first-page":"e163624","DOI":"10.1172\/jci.insight.163624","volume":"8","author":"G Li","year":"2023","unstructured":"Li G, Li X, Mahmud I, Ysaguirre J, Fekry B, Wang S, et al. Interfering with lipid metabolism through targeting CES1 sensitizes hepatocellular carcinoma for chemotherapy. JCI Insight. 2023;8:e163624. https:\/\/doi.org\/10.1172\/jci.insight.163624.","journal-title":"JCI Insight"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-15897-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15897-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15897-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:49:38Z","timestamp":1781642978000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-15897-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,25]]},"references-count":107,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15897"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-15897-4","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,25]]},"assertion":[{"value":"26 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"562"}}